Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01197638
Other study ID # Ablations Register
Secondary ID
Status Completed
Phase N/A
First received July 29, 2010
Last updated June 16, 2016
Start date June 2008
Est. completion date February 2016

Study information

Verified date June 2016
Source Stiftung Institut fuer Herzinfarktforschung
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Observational

Clinical Trial Summary

The goal of this register is the documentation of the success as well as of the complications regarding interventional therapy of cardiac arrhythmia by catheter ablation. This is the necessary basis for quality management and development of possible improvements of catheter ablation.


Description:

The interventional therapy of heartbeat disturbances by means of catheter ablation makes the curative treatment possible of numerous tachycardiac arrhythmics. By this crucial improvement of the supply of patients and its quality of life a genuine healing of a multiplicity of heartbeat disturbances became possible. Especially within the range of the ablation treatment there are relatively few con-trolled studies, which would give a broad collection of the results of the catheter ablation in the different indication areas.

Aim of the registry:

Documentation of indication, hospital course and complications during long term follow-up of patients with catheter ablation

Design:

Prospective, multicenter registry; FU-duration 12 months.

Duration:

Phase I: 2 years

Inclusion criteria:

Catheter ablation (intention to treat)

Exclusion criteria:

Missing declaration of consent


Recruitment information / eligibility

Status Completed
Enrollment 20663
Est. completion date February 2016
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- The ablation register will include all consecutive patients with a performed or attempted electrophysiological ablation

Exclusion Criteria:

- Missing signed informed consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Herz- und Gefäßklinik Bad Neustadt / Saale
Germany Vivantes Klinikum Am Urban Berlin
Germany St. Marien Hospital Bonn
Germany Klinikum Coburg Coburg
Germany Praxisklinik Herz und Gefäß, Dresden
Germany Asklepios Klinik St Georg Hamburg
Germany Universitäres Herzzentrum Hamburg Hamburg
Germany Städt Klinikum Hildesheim Hildesheim
Germany Krankenhaus München Bogenhausen München

Sponsors (1)

Lead Sponsor Collaborator
Stiftung Institut fuer Herzinfarktforschung

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Characterize consecutive patients with electrophysiological ablation in daily hospital routine in Germany. 01/06/2008-12/31/2011 No
Secondary Documentation of the technical implementation of ablation and the success of the intervention 01/06/2008-12/31/2011 No
Secondary Documentation of further necessary interventions after the initial ablation during hospital stay 01/06/2008-12/31/2011 No
Secondary Documentation of hospital mortality, serious but non-fatal complications (stroke, TIA, myocardial infarction, resuscitation), and complications caused by bleedings (serious as well as moderate) 01/06/2008-12/31/2011 No
Secondary Documentation of medication therapy at hospital discharge 01/06/2008-12/31/2011 No
Secondary Documentation of the 1-year mortality, serious but non-fatal complications (stroke, TIA, myocardial infarction, resuscitation), of heavy bleedings, of phrenicus pareses, PV-stenoses, or fistulas 01/06/2008-12/31/2011 No
Secondary Documentation of the absence of relapse and of symptomatology after one year 01/06/2008-12/31/2011 No
Secondary Documentation of needed interventions (implantation of either pacemaker, ICD or CRT, revascularization, a further ablation) during the first year after ablation 01/06/2008-12/31/2011 No
Secondary Documentation of hospitalizations during the first year after ablation 01/06/2008-12/31/2011 No
Secondary Documentation of medication therapy after 12 months 01/06/2008-12/31/2011 No
See also
  Status Clinical Trial Phase
Recruiting NCT05048602 - Drug-induced Brugada Syndrome Research Database
Completed NCT05053243 - Clinical Validation of the AliveCor Kardia 12L and 6L Devices N/A
Completed NCT01913561 - The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection N/A
Completed NCT01688648 - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft N/A
Completed NCT01396226 - A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients Phase 2
Completed NCT00756886 - Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study N/A
Terminated NCT00721149 - NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study Phase 3
Terminated NCT00624520 - Mental Stress Reduction in Defibrillator Patients Phase 3
Completed NCT00510029 - Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously Phase 1
Completed NCT00578617 - Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial N/A
Active, not recruiting NCT00135174 - Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study N/A
Completed NCT00119847 - Electrophysiological Effects of Late PCI After MI N/A
Completed NCT00023556 - Genetic Architecture of Heart Disease in Rural Brazil N/A
Completed NCT00035490 - Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators Phase 3
Completed NCT01076361 - Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study N/A
Completed NCT00004560 - Public Access Defibrillation (PAD) Community Trial Phase 3
Recruiting NCT00138931 - Genetics of Cardiovascular and Neuromuscular Disease
Completed NCT01076348 - Model 4965 Post-Approval Study
Completed NCT00622453 - Arrhythmias in Myotonic Muscular Dystrophy N/A
Completed NCT00000531 - Antiarrhythmics Versus Implantable Defibrillators (AVID) Phase 3